Chang David D 13D and 13G filings for Allogene Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-13 4:29 pm Purchase |
2024-12-31 | 13G | Allogene Therapeutics, Inc. ALLO |
Chang David D | 10,905,003 5.100% |
940,656 (+9.44%) |
Filing |
| 2024-02-14 4:32 pm Purchase |
2023-12-31 | 13G | Allogene Therapeutics, Inc. ALLO |
Chang David D | 9,964,347 5.800% |
1,536,715 (+18.23%) |
Filing |
| 2023-02-13 4:33 pm Purchase |
2022-12-31 | 13G | Allogene Therapeutics, Inc. ALLO |
Chang David D | 8,427,632 5.700% |
8,427,632 (New Position) |
Filing |